Israel Biotech Fund

Israel Biotech Fund invests exclusively in biotech companies developing drugs at or near clinical stages.

Business Model:

Revenue: $0

Employees: 0-0

Rankings

Detailed Israel Biotech Fund Information

Geographic Data

Israel Biotech Fund headquarters map

Address: Ruhrberg 3 Science Center, Bell Entrance, Pekeris Street, Rabin Science Park

City: Rehovot

State: center district

Zip: 7670212

Country: IL

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$112M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Israel Biotech Fund – Building the future of Israeli Biotech Israel Biotech Fund seeks high value returns by identifying and maximizing the success of therapeutic assets of Israel-based biotech companies. Based in Rehovot, Israel’s main Biotech hub, we invest exclusively in Biotech companies developing drugs at or near clinical stages. Our partners include two top-tier international pharmaceuticals companies, institutional investors, family offices and high net worth individuals. Our key asset is a unique team of 25 Venture Advisors, comprised of renowned industry leaders and professionals who, together with the fund’s managing partners, provide our portfolio companies with hands-on guidance and support. We don’t just invest in promising companies – we have the ability, experience and network required to identify the best opportunities and partner with our portfolio companies to help them go the distance. We provide our portfolio companies with the necessary resources for long-term sustainable growth. This approach enhances their value and the investor’s long-term capital appreciation, while strengthening Israel’s Biotech industry which increases investment opportunities. The biotechnology industry in Israel is growing with enormous potential and we are determined to realize its full potential and real value.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
3/2020 BioSight Series C 0
6/2017 Gamida Cell Series F 0
2/2017 Pharma Two B Equity 30M
5/2019 Ayala Pharmaceuticals Series B 0
9/2022 MediWound Post-IPO Equity 30M
5/2021 Splisense Series B 0
11/2022 Nectin Therapeutics Series A 25M
11/2021 Vensica Medical Venture Round 0
12/2020 BioSight Series C 0
1/2019 Biond Biologics Series B 0
6/2016 Vidac Pharma Series A 0
4/2018 Ayala Pharmaceuticals Series A 0
11/2021 Vensica Medical Venture Round 0
5/2021 Splisense Series B 0
12/2020 BioSight Series C 0
3/2020 BioSight Series C 0
5/2019 Ayala Pharmaceuticals Series B 0
1/2019 Biond Biologics Series B 0
4/2018 Ayala Pharmaceuticals Series A 0
6/2017 Gamida Cell Series F 0
2/2017 Pharma Two B Series C 0
6/2016 Vidac Pharma Series A 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research